Two-year outcomes after deployment of XIENCE V everolimus-eluting stents in patients undergoing percutaneous coronary intervention of bifurcation lesions: a report from the SPIRIT V single arm study.

Džavík, Vladimír

Two-year outcomes after deployment of XIENCE V everolimus-eluting stents in patients undergoing percutaneous coronary intervention of bifurcation lesions: a report from the SPIRIT V single arm study. [electronic resource] - Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions Sep 2013 - E163-72 p. digital

Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1522-726X

10.1002/ccd.24775 doi


Asia
Canada
Cardiovascular Agents--administration & dosage
Coronary Angiography
Coronary Artery Disease--diagnosis
Coronary Thrombosis--etiology
Drug-Eluting Stents
Europe
Everolimus
Female
Humans
Male
Middle Aged
Myocardial Infarction--etiology
New Zealand
Percutaneous Coronary Intervention--adverse effects
Platelet Aggregation Inhibitors--therapeutic use
Prospective Studies
Prosthesis Design
Risk Factors
Sirolimus--administration & dosage
South Africa
Time Factors
Treatment Outcome